BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//WA Innovation Calendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:WA Innovation Calendar
X-ORIGINAL-URL:https://wainnovationcalendar.com.au
X-WR-CALDESC:Events for WA Innovation Calendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Perth
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:AWST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Perth:20240712T090000
DTEND;TZID=Australia/Perth:20240713T173000
DTSTAMP:20260608T123746
CREATED:20240329T044512Z
LAST-MODIFIED:20260407T055748Z
UID:10002052-1720774800-1720891800@wainnovationcalendar.com.au
SUMMARY:Bioshares Biotech Summit
DESCRIPTION:2024 Bioshares Summit\nBioshares is delighted to announce that the 18th Bioshares Biotech Summit will be held at the Esplanade Hotel in Fremantle\, Western Australia on the 12-13 July 2024 \nFollowing on from a very successful event in Hobart during 2023 which had a record 200 attendees\, the move to Fremantle will provide the opportunity for biotech companies to access new retail and institutional investors in WA\, and for biotechs and service providers to build closer links with a very active biotech sector in the state which enjoys strong support from the WA State Government. \nPerth has a very active biotech R&D sector which includes the University of WA\, the Harry Perkins Institute of Medical Research\, the Lions Eye Institute\, the Perron Institute for Neurological and Translation Science\, and the Telethon Kids Institute. It now has 244 life science companies which has doubled in the last six years. \nSuccessful technologies that were seeded in Perth include Sirtex Medical (sold to China Grand Pharmaceutical in 2018 for $1.9 billion)\, the ADAPT tissue processing technology that has been implanted in over 35\,000 patients from Anteris Technologies\, and three drugs (for Duchenne muscular dystrophy) that were discovered at the Perron Institute and licensed to Sarepta Therapeutics and subsequently approved by the FDA. \nOur Event Partner for the Summit is the WA Government and our Destination Sponsor is Business Events Perth. Other groups interested in becoming involved with this event please email us at summit@bioshares.com.au. \nThe Summit will officially commence on Friday 12 July. On Thursday 11 July\, the annual CEO Dinner will take place. A new aspect to the event this year will be a CFO dinner on the same evening. Registration will open in April. And accommodation can now be booked here. \nThe Summit is an ideal event for fund managers\, stockbrokers and investment bankers active in the sector as well as retail investors who have a committed interest in biotech stocks or are looking to build their knowledge and networks in this space. It remains one of the key\, high-level networking events in the sector. \nWe hope you can make it to this year’s Summit! \nThe Bioshares Team
URL:https://wainnovationcalendar.com.au/event/bioshares-biotech-summit/
LOCATION:Fremantle\, WA\, Fremantle\, WA\, 6160\, Australia
CATEGORIES:Conference / Summit / Symposium
END:VEVENT
END:VCALENDAR